Advertisement

Diagnosis Confirmation and Screening of Wilson Disease

  • Marinos Pericleous
  • Claire Kelly
  • Michael L. SchilskyEmail author
Chapter
Part of the Clinical Gastroenterology book series (CG)

Abstract

The diagnosis of Wilson disease (WD) can be challenging and may require a multidisciplinary evaluation utilizing clinical and biochemical tests. Molecular genetic analysis of the WD gene, ATP7B has enhanced diagnosis of this disorder and can be used for family screening of siblings and confirmation in challenging cases. The presentation of the disease is variable and can range from complete lack of symptoms to catastrophic, life-threatening sequelae affecting the liver, brain, and other body systems. In this section, we will focus on the diagnostic principles for establishing a diagnosis of WD and screening for WD in other family members.

Keywords

Wilson disease Ceruloplasmin Copper metabolism Diagnosis ATP7B 

References

  1. 1.
    Compston A. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295–509. Brain. 2009;132(Pt 8):1997–2001.Google Scholar
  2. 2.
    Bearn AG, Kunkel HG. Abnormalities of copper metabolism in Wilson’s disease and their relationship to the aminoaciduria. J Clin Invest. 1954;33(3):400–9.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Hall HC. La dégénérescence hépato-lenticulaire : maladie de Wilson, pseudo-sclérose. Paris: Masson; 1921. xi. p. 361.Google Scholar
  4. 4.
    European Association for Study of L. EASL clinical practice guidelines: Wilson’s disease. J Hepatol. 2012;56(3):671–85.CrossRefGoogle Scholar
  5. 5.
    Frydman M, Bonne-Tamir B, Farrer LA, Conneally PM, Magazanik A, Ashbel S, et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci U S A. 1985;82(6):1819–21.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet. 1993;3(1):7–13.CrossRefPubMedGoogle Scholar
  7. 7.
    Chelly J, Tumer Z, Tonnesen T, Petterson A, Ishikawa-Brush Y, Tommerup N, et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet. 1993;3(1):14–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993;5(4):327–37.CrossRefPubMedGoogle Scholar
  9. 9.
    Mercer JF, Livingston J, Hall B, Paynter JA, Begy C, Chandrasekharappa S, et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat Genet. 1993;3(1):20–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Petrukhin K, Fischer SG, Pirastu M, Tanzi RE, Chernov I, Devoto M, et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet. 1993;5(4):338–43.CrossRefPubMedGoogle Scholar
  11. 11.
    Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993;5(4):344–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Glazebrook A. Wilson’s disease. Edinburgh MJ. 1945;52(Feb.):83–7.Google Scholar
  13. 13.
    Stanbury JB, Wyngaarden JB, Fredrickson DS. The metabolic basis of inherited disease. 4th ed. New York/London: McGraw-Hill; 1978.Google Scholar
  14. 14.
    Schilsky ML, Tavill AS. Wilson disease. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff’s diseases of the liver. 11th ed: Wiley-Blackwell; 2011.Google Scholar
  15. 15.
    Mahajan R, Zachariah U. Images in clinical medicine. Wing-beating tremor. N Engl J Med. 2014;371(1):e1.CrossRefPubMedGoogle Scholar
  16. 16.
    LeWitt PA, Wilson’s Disease CA. International neurology: Wiley-Blackwell; 2010. p. 644–7.Google Scholar
  17. 17.
    Choudhary N, Joshi L, Duggal A, Puri V, Khwaja GA. Isolated lingual involvement in Wilson’s disease. J Neurosci Rural Pract. 2015;6(3):431–3.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    De Smet HJ, Paquier P, Verhoeven J, Marien P. The cerebellum: its role in language and related cognitive and affective functions. Brain Lang. 2013;127(3):334–42.CrossRefPubMedGoogle Scholar
  19. 19.
    Wolf U, Rapoport MJ, Schweizer TA. Evaluating the affective component of the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 2009;21(3):245–53.CrossRefPubMedGoogle Scholar
  20. 20.
    Zimbrean PC, Schilsky ML. Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry. 2014;36(1):53–62.CrossRefPubMedGoogle Scholar
  21. 21.
    Wang H, Zhou Z, Hu J, Han Y, Wang X, Cheng N, et al. Renal impairment in different phenotypes of Wilson disease. Neurol Sci. 2015;36(11):2111–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Weiss KH, Van de Moortele M, Gotthardt DN, Pfeiffenberger J, Seessle J, Ullrich E, et al. Bone demineralisation in a large cohort of Wilson disease patients. J Inherit Metab Dis. 2015;38(5):949–56.CrossRefPubMedGoogle Scholar
  23. 23.
    Zhou XX, Qin HL, Li XH, Huang HW, Liang YY, Liang XL, et al. Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging. Neurol India. 2014;62(4):362–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Rosenfield N, Grand RJ, Watkins JB, Ballantine TV, Levey RH. Cholelithiasis and Wilson disease. J Pediatr. 1978;92(2):210–3.CrossRefPubMedGoogle Scholar
  25. 25.
    El Raziky MS, Ali A, El Shahawy A, Hamdy MM. Acute hemolytic anemia as an initial presentation of Wilson disease in children. J Pediatr Hematol Oncol. 2014;36(3):173–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Misztal S, Weiss B, Janukowicz-Lorenz H. Latent hemolytic syndrome in a case of Wilson’ disease. Neurol Neurochir Pol. 1974;8(1):123–6.PubMedGoogle Scholar
  27. 27.
    Furrer HU, Tonz O. Acute hemolysis in morbus Wilson (author’s transl). Z Kinderheilkd. 1974;118(2):147–62.PubMedGoogle Scholar
  28. 28.
    Buchanan GR. Acute hemolytic anemia as a presenting manifestation of Wilson disease. J Pediatr. 1975;86(2):245–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Forman SJ, Kumar KS, Redeker AG, Hochstein P. Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms. Am J Hematol. 1980;9(3):269–75.CrossRefPubMedGoogle Scholar
  30. 30.
    Roberts EA, Schilsky ML. American Association for Study of liver D. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47(6):2089–111.CrossRefPubMedGoogle Scholar
  31. 31.
    Factor SM, Cho S, Sternlieb I, Scheinberg IH, Goldfischer S. The cardiomyopathy of Wilson’s disease. Myocardial alterations in nine cases. Virchows Arch A Pathol Anat Histol. 1982;397(3):301–11.CrossRefPubMedGoogle Scholar
  32. 32.
    Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Swamy HS. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson’s disease. J Neurol Sci. 2004;217(1):37–40.CrossRefPubMedGoogle Scholar
  33. 33.
    Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23(3):139–42.CrossRefPubMedGoogle Scholar
  34. 34.
    Siermerling E, Oloff H. Pseudosclerose mit Cornealring und doppelseitiger Scheinkatarakt, die nur bei seitlicher Beleuchtung sichtbar und die nach der Verletzung durch Kupfersplitter entstehenden Katarakten ahnlich ist. Klin Wochenschr. 1922;1:1087–9.CrossRefGoogle Scholar
  35. 35.
    Jess A. Hornhautverkupferung in Form des Fleischerschen Pigmentringes bei der Pseudosklerose. Klin Mbl Augenheilk. 1922;69:218.Google Scholar
  36. 36.
    Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson’s disease: an experience over three decades. Gut. 2000;46(3):415–9.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson’s disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997;113(1):212–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Fleming CR, Dickson ER, Hollenhorst RW, Goldstein NP, McCall JT, Baggenstoss AH. Pigmented corneal rings in a patient with primary biliary cirrhosis. Gastroenterology. 1975;69(1):220–5.PubMedGoogle Scholar
  39. 39.
    Mandal SK, Mandal L, Datta S, Bandyopadhyay D. Primary sclerosing cholangitis : an atypical presentation. J Assoc Physicians India. 2013;61(7):494–5.PubMedGoogle Scholar
  40. 40.
    Cairns JE, Williams HP, Walshe JM. “Sunflower cataract” in Wilson’s disease. Br Med J. 1969;3(5662):95–6.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Atanasiu RL, Stea D, Mateescu MA, Vergely C, Dalloz F, Briot F, et al. Direct evidence of caeruloplasmin antioxidant properties. Mol Cell Biochem. 1998;189(1–2):127–35.CrossRefPubMedGoogle Scholar
  42. 42.
    Scheinberg IH, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson’s disease). Science. 1952;116(3018):484–5.CrossRefPubMedGoogle Scholar
  43. 43.
    Sternlieb I, Scheinberg IH. Prevention of Wilson’s disease in asymptomatic patients. N Engl J Med. 1968;278(7):352–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Gibbs K, Walshe JM. A study of the caeruloplasmin concentrations found in 75 patients with Wilson’s disease, their kinships and various control groups. Q J Med. 1979;48(191):447–63.PubMedGoogle Scholar
  45. 45.
    Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine (Baltimore). 1992;71(3):139–64.CrossRefGoogle Scholar
  46. 46.
    Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med. 1991;115(9):720–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci P. Screening for Wilson’s disease in patients with liver diseases by serum ceruloplasmin. J Hepatol. 1997;27(2):358–62.CrossRefPubMedGoogle Scholar
  48. 48.
    Sanchez-Albisua I, Garde T, Hierro L, Camarena C, Frauca E, de la Vega A, et al. A high index of suspicion: the key to an early diagnosis of Wilson’s disease in childhood. J Pediatr Gastroenterol Nutr. 1999;28(2):186–90.CrossRefPubMedGoogle Scholar
  49. 49.
    Perman JA, Werlin SL, Grand RJ, Watkins JB. Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children. J Pediatr. 1979;94(4):564–8.CrossRefPubMedGoogle Scholar
  50. 50.
    Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson’s disease. Hepatology. 1992;15(4):609–15.CrossRefPubMedGoogle Scholar
  51. 51.
    Giacchino R, Marazzi MG, Barabino A, Fasce L, Ciravegna B, Famularo L, et al. Syndromic variability of Wilson’s disease in children. Clinical study of 44 cases. Ital J Gastroenterol Hepatol. 1997;29(2):155–61.PubMedGoogle Scholar
  52. 52.
    Gross JB Jr, Ludwig J, Wiesner RH, McCall JT, LaRusso NF. Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology. 1985;89(2):272–8.CrossRefPubMedGoogle Scholar
  53. 53.
    Cocos R, Sendroiu A, Schipor S, Bohiltea LC, Sendroiu I, Raicu F. Genotype-phenotype correlations in a mountain population community with high prevalence of Wilson’s disease: genetic and clinical homogeneity. PLoS One. 2014;9(6):e98520.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Scheinberg IH, Sternlieb I. Wilson’s disease: W B Saunders; 1984.Google Scholar
  55. 55.
    Ferenci P, Steindl-Munda P, Vogel W, Jessner W, Gschwantler M, Stauber R, et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson’s disease. Clin Gastroenterol Hepatol. 2005;3(8):811–8.CrossRefPubMedGoogle Scholar
  56. 56.
    Jacobs DA, Markowitz CE, Liebeskind DS, Galetta SL. The “double panda sign” in Wilson’s disease. Neurology. 2003;61(7):969.CrossRefPubMedGoogle Scholar
  57. 57.
    Acute Liver Failure Study Group: Overview 2017 [Available from: http://www.utsouthwestern.edu/labs/acute-liver/overview/.
  58. 58.
    Korman JD, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH Jr, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology. 2008;48(4):1167–74.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology. 1991;100(4):1129–34.CrossRefPubMedGoogle Scholar
  60. 60.
    Schilsky ML. Diagnosis and treatment of Wilson’s disease. Pediatr Transplant. 2002;6(1):15–9.CrossRefPubMedGoogle Scholar
  61. 61.
    Kamate M, Prashanth GP, Gandhi S. A boy with sapphire thumbnails: Lunulae Ceruleae. Indian J Pediatr. 2014;81(7):737–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Marinos Pericleous
    • 1
    • 2
  • Claire Kelly
    • 1
    • 2
  • Michael L. Schilsky
    • 3
    Email author
  1. 1.Department of Gastroenterology and HepatologyRoyal Surrey County HospitalSurreyUK
  2. 2.Department of Clinical and Experimental MedicineUniversity of SurreySurreyUK
  3. 3.Division of Digestive Diseases and Transplant and Immunology, Departments of Medicine and SurgeryYale UniversityNew HavenUSA

Personalised recommendations